{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:06:45Z","timestamp":1790662005370,"version":"4.1.0"},"reference-count":224,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Growth hormone (GH) and its mediator insulin-like growth factor-1 (IGF-1) have manifold effects on the kidneys. GH and IGF receptors are abundantly expressed in the kidney, including the glomerular and tubular cells. GH can act either directly on the kidneys or via circulating or paracrine-synthesized IGF-1. The GH\/IGF-1 system regulates glomerular hemodynamics, renal gluconeogenesis, tubular sodium and water, phosphate, and calcium handling, as well as renal synthesis of 1,25 (OH)<jats:sub>2<\/jats:sub> vitamin D<jats:sub>3<\/jats:sub> and the antiaging hormone Klotho. The latter also acts as a coreceptor of the phosphaturic hormone fibroblast-growth factor 23 in the proximal tubule. Recombinant human GH (rhGH) is widely used in the treatment of short stature in children, including those with chronic kidney disease (CKD). Animal studies and observations in acromegalic patients demonstrate that GH-excess can have deleterious effects on kidney health, including glomerular hyperfiltration, renal hypertrophy, and glomerulosclerosis. In addition, elevated GH in patients with poorly controlled type 1 diabetes mellitus was thought to induce podocyte injury and thereby contribute to the development of diabetic nephropathy. This manuscript gives an overview of the physiological actions of GH\/IGF-1 on the kidneys and the multiple alterations of the GH\/IGF-1 system and its consequences in patients with acromegaly, CKD, nephrotic syndrome, and type 1 diabetes mellitus. Finally, the impact of short- and long-term treatment with rhGH\/rhIGF-1 on kidney function in patients with kidney diseases will be discussed.<\/jats:p>","DOI":"10.1007\/s00467-021-05097-6","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T09:03:02Z","timestamp":1624006982000},"page":"2511-2530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Renal effects of growth hormone in health and in kidney disease"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9601-7813","authenticated-orcid":false,"given":"Dieter","family":"Haffner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Grund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"Leifheit-Nestler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"5097_CR1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/er.2013-1071","volume":"35","author":"P Kamenick\u00fd","year":"2014","unstructured":"Kamenick\u00fd P, Mazziotti G, Lomb\u00e8s M, Giustina A, Chanson P (2014) Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr Rev 35:234\u2013281","journal-title":"Endocr Rev"},{"key":"5097_CR2","first-page":"423","volume":"17","author":"S Feld","year":"1996","unstructured":"Feld S, Hirschberg R (1996) Growth hormone, the insulin-like growth factor system, and the kidney. Endocr Rev 17:423\u2013480","journal-title":"Endocr Rev"},{"key":"5097_CR3","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/ndt\/14.8.1853","volume":"14","author":"MR Hammerman","year":"1999","unstructured":"Hammerman MR (1999) The growth hormone-insulin-like growth factor axis in kidney re-revisited. Nephrol Dial Transplant 14:1853\u20131860","journal-title":"Nephrol Dial Transplant"},{"key":"5097_CR4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF00869745","volume":"6","author":"GD Ogle","year":"1992","unstructured":"Ogle GD, Rosenberg AR, Kainer G (1992) Renal effects of growth hormone. I. Renal function and kidney growth. Pediatr Nephrol 6:394\u2013398","journal-title":"Pediatr Nephrol"},{"key":"5097_CR5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00874021","volume":"6","author":"GD Ogle","year":"1992","unstructured":"Ogle GD, Rosenberg AR, Kainer G (1992) Renal effects of growth hormone. II. Electrolyte homeostasis and body composition. Pediatr Nephrol 6:483\u2013489","journal-title":"Pediatr Nephrol"},{"key":"5097_CR6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11154-007-9025-5","volume":"7","author":"NJ Lanning","year":"2006","unstructured":"Lanning NJ, Carter-Su C (2006) Recent advances in growth hormone signaling. Rev Endocr Metab Disord 7:225\u2013235","journal-title":"Rev Endocr Metab Disord"},{"key":"5097_CR7","doi-asserted-by":"crossref","first-page":"T11","DOI":"10.1530\/JME-17-0254","volume":"61","author":"LA Bach","year":"2018","unstructured":"Bach LA (2018) IGF-binding proteins. J Mol Endocrinol 61:T11\u2013T28","journal-title":"J Mol Endocrinol"},{"key":"5097_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fendo.2018.00035","volume":"9","author":"F Dehkhoda","year":"2018","unstructured":"Dehkhoda F, Lee CMM, Medina J, Brooks AJ (2018) The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological aspects. Front Endocrinol (Lausanne) 9:35","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5097_CR9","doi-asserted-by":"crossref","first-page":"9905","DOI":"10.1016\/S0021-9258(18)81745-8","volume":"264","author":"LS Mathews","year":"1989","unstructured":"Mathews LS, Enberg B, Norstedt G (1989) Regulation of rat growth hormone receptor gene expression. J Biol Chem 264:9905\u20139910","journal-title":"J Biol Chem"},{"key":"5097_CR10","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1210\/endo.131.6.1446640","volume":"131","author":"E Chin","year":"1992","unstructured":"Chin E, Zhou J, Bondy CA (1992) Renal growth hormone receptor gene expression: Relationship to renal insulin-like growth factor system. Endocrinology 131:3061\u20133066","journal-title":"Endocrinology"},{"key":"5097_CR11","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1210\/en.2008-0143","volume":"149","author":"P Kamenicky","year":"2008","unstructured":"Kamenicky P, Viengchareun S, Blanchard A, Meduri G, Zizzari P, Imbert-Teboul M, Doucet A, Chanson P, Lomb\u00e8s M (2008) Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly. Endocrinology 149:3294\u20133305","journal-title":"Endocrinology"},{"key":"5097_CR12","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/en.2006-1285","volume":"148","author":"GR Reddy","year":"2007","unstructured":"Reddy GR, Pushpanathan MJ, Ransom RF, Holzman LB, Brosius FC 3rd, Diakonova M, Mathieson P, Saleem MA, List EO, Kopchick JJ, Frank SJ, Menon RK (2007) Identification of the glomerular podocyte as a target for growth hormone action. Endocrinology 148:2045\u20132055","journal-title":"Endocrinology"},{"key":"5097_CR13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1523-1755.2003.00117.x","volume":"64","author":"U Meinhardt","year":"2003","unstructured":"Meinhardt U, Ebl\u00e9 A, Besson A, Strasburger CJ, Sraer JD, Mullis PE (2003) Regulation of growth-hormone-receptor gene expression by growth hormone and pegvisomant in human mesangial cells. Kidney Int 64:421\u2013430","journal-title":"Kidney Int"},{"key":"5097_CR14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1681\/ASN.V1181419","volume":"11","author":"SQ Doi","year":"2000","unstructured":"Doi SQ, Jacot TA, Sellitti DF, Hirszel P, Hirata MH, Striker GE, Striker LJ (2000) Growth hormone increases inducible nitric oxide synthase expression in mesangial cells. J Am Soc Nephrol 11:1419\u20131425","journal-title":"J Am Soc Nephrol"},{"key":"5097_CR15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1073\/pnas.81.3.935","volume":"81","author":"AJ D'Ercole","year":"1984","unstructured":"D'Ercole AJ, Stiles AD, Underwood LE (1984) Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci U S A 81:935\u2013939","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5097_CR16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1210\/mend-1-3-243","volume":"1","author":"CT Roberts Jr","year":"1987","unstructured":"Roberts CT Jr, Lasky SR, Lowe WL Jr, Seaman WT, LeRoith D (1987) Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol 1:243\u2013248","journal-title":"Mol Endocrinol"},{"key":"5097_CR17","first-page":"474","volume":"259","author":"SA Rogers","year":"1990","unstructured":"Rogers SA, Miller SB, Hammerman MR (1990) Growth hormone stimulates IGF I gene expression in isolated rat renal collecting duct. Am J Phys 259:474","journal-title":"Am J Phys"},{"key":"5097_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0303-7207(97)00123-8","volume":"132","author":"DJ Lindenbergh-Kortleve","year":"1997","unstructured":"Lindenbergh-Kortleve DJ, Rosato RR, van Neck JW, Nauta J, van Kleffens M, Groffen C, Zwarthoff EC, Drop SL (1997) Gene expression of the insulin-like growth factor system during mouse kidney development. Mol Cell Endocrinol 132:81\u201391","journal-title":"Mol Cell Endocrinol"},{"key":"5097_CR19","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1210\/endo.130.6.1375897","volume":"130","author":"E Chin","year":"1992","unstructured":"Chin E, Zhou J, Bondy C (1992) Anatomical relationships in the patterns of insulin-like growth factor (IGF)-I, IGF binding protein-1, and IGF-I receptor gene expression in the rat kidney. Endocrinology 130:3237\u20133245","journal-title":"Endocrinology"},{"key":"5097_CR20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ghir.2004.06.003","volume":"14","author":"V Cingel-Risti\u0107","year":"2004","unstructured":"Cingel-Risti\u0107 V, Flyvbjerg A, Drop SL (2004) The physiological and pathophysiological roles of the GH\/IGF-axis in the kidney: lessons from experimental rodent models. Growth Hormon IGF Res 14:418\u2013430","journal-title":"Growth Hormon IGF Res"},{"key":"5097_CR21","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/mend-4-9-1386","volume":"4","author":"CA Bondy","year":"1990","unstructured":"Bondy CA, Werner H, Roberts CT Jr, LeRoith D (1990) Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol Endocrinol 4:1386\u20131398","journal-title":"Mol Endocrinol"},{"key":"5097_CR22","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1681\/ASN.V651511","volume":"6","author":"R Rabkin","year":"1995","unstructured":"Rabkin R, Brody M, Lu LH, Chan C, Shaheen AM, Gillett N (1995) Expression of the genes encoding the rat renal insulin-like growth factor-I system. J Am Soc Nephrol 6:1511\u20131518","journal-title":"J Am Soc Nephrol"},{"key":"5097_CR23","first-page":"962","volume":"75","author":"E Chin","year":"1992","unstructured":"Chin E, Bondy C (1992) Insulin-like growth factor system gene expression in the human kidney. J Clin Endocrinol Metab 75:962\u2013968","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR24","first-page":"156","volume":"78","author":"E Chin","year":"1994","unstructured":"Chin E, Michels K, Bondy CA (1994) Partition of insulin-like growth factor (IGF)-binding sites between the IGF-I and IGF-II receptors and IGF-binding proteins in the human kidney. J Clin Endocrinol Metab 78:156\u2013164","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR25","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1681\/ASN.2007010020","volume":"18","author":"A Staruschenko","year":"2007","unstructured":"Staruschenko A, Pochynyuk O, Vandewalle A, Bugaj V, Stockand JD (2007) Acute regulation of the epithelial na+ channel by phosphatidylinositide 3-OH kinase signaling in native collecting duct principal cells. J Am Soc Nephrol 18:1652\u20131661","journal-title":"J Am Soc Nephrol"},{"key":"5097_CR26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/sj.ki.5002018","volume":"71","author":"E Gonzalez-Rodriguez","year":"2007","unstructured":"Gonzalez-Rodriguez E, Gaeggeler HP, Rossier BC (2007) IGF-1 vs insulin: respective roles in modulating sodium transport via the PI-3 kinase\/Sgk1 pathway in a cortical collecting duct cell line. Kidney Int 71:116\u2013125","journal-title":"Kidney Int"},{"key":"5097_CR27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/er.2010-0009","volume":"32","author":"EO List","year":"2011","unstructured":"List EO, Sackmann-Sala L, Berryman DE, Funk K, Kelder B, Gosney ES, Okada S, Ding J, Cruz-Topete D, Kopchick JJ (2011) Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-\/-) mouse. Endocr Rev 32:356\u2013386","journal-title":"Endocr Rev"},{"key":"5097_CR28","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/me.2011-0047","volume":"25","author":"SM Nordstrom","year":"2011","unstructured":"Nordstrom SM, Tran JL, Sos BC, Wagner KU, Weiss EJ (2011) Liver-derived IGF-I contributes to GH-dependent increases in lean mass and bone mineral density in mice with comparable levels of circulating GH. Mol Endocrinol 25:1223\u20131230","journal-title":"Mol Endocrinol"},{"key":"5097_CR29","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI104584","volume":"41","author":"J Corvilain","year":"1962","unstructured":"Corvilain J, Abramow M, Bergans A (1962) Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man. J Clin Invest 41:1230\u20131235","journal-title":"J Clin Invest"},{"key":"5097_CR30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/ki.1989.65","volume":"35","author":"R Hirschberg","year":"1989","unstructured":"Hirschberg R, Rabb H, Bergamo R, Kopple JD (1989) The delayed effect of growth hormone on renal function in humans. Kidney Int 35:865\u2013870","journal-title":"Kidney Int"},{"key":"5097_CR31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000167592","volume":"8","author":"RR Hirschberg","year":"1988","unstructured":"Hirschberg RR, Kopple JD (1988) Increase in renal plasma flow and glomerular filtration rate during growth hormone treatment may be mediated by insulin-like growth factor I. Am J Nephrol 8:249\u2013254","journal-title":"Am J Nephrol"},{"key":"5097_CR32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000185920","volume":"55","author":"D Haffner","year":"1990","unstructured":"Haffner D, Ritz E, Mehls O, Rosman J, Blum W, Heinrich U, Hubinger A (1990) Growth hormone induced rise in glomerular filtration rate is not obliterated by angiotensin-converting enzyme inhibitors. Nephron 55:63\u201368","journal-title":"Nephron"},{"key":"5097_CR33","first-page":"266","volume":"32","author":"D Haffner","year":"1989","unstructured":"Haffner D, Zacharewicz S, Mehls O, Heinrich U, Ritz E (1989) The acute effect of growth hormone on GFR is obliterated in chronic renal failure. Clin Nephrol 32:266\u2013269","journal-title":"Clin Nephrol"},{"key":"5097_CR34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2362.1981.tb02018.x","volume":"11","author":"JS Christiansen","year":"1981","unstructured":"Christiansen JS, Gammelgaard J, Orskov H, Andersen AR, Telmer S, Parving HH (1981) Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Investig 11:487\u2013490","journal-title":"Eur J Clin Investig"},{"key":"5097_CR35","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1530\/acta.0.0890796","volume":"89","author":"HH Parving","year":"1978","unstructured":"Parving HH, Noer I, Mogensen CE, Svendsen PA (1978) Kidney function in normal man during short-term growth hormone infusion. Acta Endocrinol 89:796\u2013800","journal-title":"Acta Endocrinol"},{"key":"5097_CR36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2362.1992.tb01827.x","volume":"22","author":"U Baumann","year":"1992","unstructured":"Baumann U, Eisenhauer T, Hartmann H (1992) Increase of glomerular filtration rate and renal plasma flow by insulin-like growth factor-I during euglycaemic clamping in anaesthetized rats. Eur J Clin Investig 22:204\u2013209","journal-title":"Eur J Clin Investig"},{"key":"5097_CR37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/acta.0.1210101","volume":"121","author":"HP Guler","year":"1989","unstructured":"Guler HP, Eckardt KU, Zapf J, Bauer C, Froesch ER (1989) Insulin-like growth factor I increase glomerular filtration rate and renal plasma flow in man. Acta Endocrinol 121:101\u2013106","journal-title":"Acta Endocrinol"},{"key":"5097_CR38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1172\/JCI113878","volume":"83","author":"R Hirschberg","year":"1989","unstructured":"Hirschberg R, Kopple JD (1989) Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest 83:326\u2013330","journal-title":"J Clin Invest"},{"key":"5097_CR39","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1681\/ASN.V291417","volume":"2","author":"R Hirschberg","year":"1992","unstructured":"Hirschberg R, Kopple JD (1992) The growth hormone-insulin-like growth factor I axis and renal glomerular function. J Am Soc Nephrol 2:1417\u20131422","journal-title":"J Am Soc Nephrol"},{"key":"5097_CR40","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1172\/JCI115119","volume":"87","author":"R Hirschberg","year":"1991","unstructured":"Hirschberg R, Kopple JD, Blantz RC, Tucker BJ (1991) Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J Clin Invest 87:1200\u20131206","journal-title":"J Clin Invest"},{"key":"5097_CR41","doi-asserted-by":"crossref","first-page":"F120","DOI":"10.1152\/ajpcell.1998.274.1.C120","volume":"274","author":"B T\u00f6nshoff","year":"1998","unstructured":"T\u00f6nshoff B, Kaskel FJ, Moore LC (1998) Effects of insulin-like growth factor I on the renal juxtamedullary microvasculature. Am J Phys 274:F120\u2013F128","journal-title":"Am J Phys"},{"key":"5097_CR42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0272-6386(12)81085-7","volume":"21","author":"B T\u00f6nshoff","year":"1993","unstructured":"T\u00f6nshoff B, Nowack R, Kurilenko S, Blum WF, Seyberth HW, Mehls O, Ritz E (1993) Growth hormone-induced glomerular hyperfiltration is dependent on vasodilating prostanoids. Am J Kidney Dis 21:145\u2013151","journal-title":"Am J Kidney Dis"},{"key":"5097_CR43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ki.1994.78","volume":"45","author":"H Tsukahara","year":"1994","unstructured":"Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS (1994) Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 45:598\u2013604","journal-title":"Kidney Int"},{"key":"5097_CR44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.mvr.2009.05.006","volume":"78","author":"R Nissel","year":"2009","unstructured":"Nissel R, Fischer DC, Puhlmann A, Holdt-Lehmann B, Mitzner A, Petzsch M, Korber T, Tiess M, Schmidt R, Haffner D (2009) Short-term growth hormone treatment and microcirculation: effects in patients with chronic kidney disease. Microvasc Res 78:246\u2013252","journal-title":"Microvasc Res"},{"key":"5097_CR45","doi-asserted-by":"crossref","first-page":"31148","DOI":"10.1074\/jbc.M110.132332","volume":"285","author":"PA Kumar","year":"2010","unstructured":"Kumar PA, Kotlyarevska K, Dejkhmaron P, Reddy GR, Lu C, Bhojani MS, Menon RK (2010) Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: a novel action of gh with implications for the pathogenesis of diabetic nephropathy. J Biol Chem 285:31148\u201331156","journal-title":"J Biol Chem"},{"key":"5097_CR46","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1159\/000330078","volume":"27","author":"CX Li","year":"2011","unstructured":"Li CX, Xia M, Han WQ, Li XX, Zhang C, Boini KM, Liu XC, Li PL (2011) Reversal by growth hormone of homocysteine-induced epithelial-to-mesenchymal transition through membrane raft-redox signaling in podocytes. Cell Physiol Biochem 27:691\u2013702","journal-title":"Cell Physiol Biochem"},{"key":"5097_CR47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ghir.2005.02.008","volume":"15","author":"TL Vasylyeva","year":"2005","unstructured":"Vasylyeva TL, Chen X, Ferry RJ Jr (2005) Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis. Growth Hormon IGF Res 15:207\u2013214","journal-title":"Growth Hormon IGF Res"},{"key":"5097_CR48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41581-019-0159-y","volume":"15","author":"M Levi","year":"2019","unstructured":"Levi M, Gratton E, Forster IC, Hernando N, Wagner CA, Biber J, Sorribas V, Murer H (2019) Mechanisms of phosphate transport. Nat Rev Nephrol 15:482\u2013500","journal-title":"Nat Rev Nephrol"},{"key":"5097_CR49","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1172\/JCI105036","volume":"43","author":"J Corvilain","year":"1964","unstructured":"Corvilain J, Abramow M (1964) Effect of growth hormone on tubular transport of phosphate in normal and parathyroidectomized dogs. J Clin Invest 43:1608\u20131612","journal-title":"J Clin Invest"},{"key":"5097_CR50","doi-asserted-by":"crossref","unstructured":"Zivicnjak M, Schnabel D, Staude H, Even G, Marx M, Beetz R, Holder M, Billing H, Fischer DC, Rabl W, Schumacher M, Hiort O, Haffner D, Hypophosphatemic Rickets Study Group of the Arbeitsgemeinschaft fur Padiatrische Endokrinologie and Gesellschaft fur Padiatrische Nephrologie (2011) Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion. J Clin Endocrinol Metab 96:2097","DOI":"10.1210\/jc.2011-0399"},{"key":"5097_CR51","first-page":"428","volume":"126","author":"R Hirschberg","year":"1995","unstructured":"Hirschberg R, Ding H, Wanner C (1995) Effects of insulin-like growth factor I on phosphate transport in cultured proximal tubule cells. J Lab Clin Med 126:428\u2013434","journal-title":"J Lab Clin Med"},{"key":"5097_CR52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s004240050759","volume":"437","author":"AW Jehle","year":"1998","unstructured":"Jehle AW, Forgo J, Biber J, Lederer E, Krapf R, Murer H (1998) IGF-I and vanadate stimulate na\/pi-cotransport in OK cells by increasing type II na\/pi-cotransporter protein stability. Pflugers Arch 437:149\u2013154","journal-title":"Pflugers Arch"},{"key":"5097_CR53","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1172\/JCI115312","volume":"88","author":"R Quigley","year":"1991","unstructured":"Quigley R, Baum M (1991) Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. J Clin Invest 88:368\u2013374","journal-title":"J Clin Invest"},{"key":"5097_CR54","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7326\/0003-4819-152-9-201005040-00007","volume":"152","author":"U Meinhardt","year":"2010","unstructured":"Meinhardt U, Nelson AE, Hansen JL, Birzniece V, Clifford D, Leung KC, Graham K, Ho KK (2010) The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial. Ann Intern Med 152:568\u2013577","journal-title":"Ann Intern Med"},{"key":"5097_CR55","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1126\/science.125.3253.884","volume":"125","author":"JC Beck","year":"1957","unstructured":"Beck JC, McGarry EE, Dyrenfurth I, Venning EH (1957) Metabolic effects of human and monkey growth hormone in man. Science 125:884\u2013885","journal-title":"Science"},{"key":"5097_CR56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1096-6374(03)00011-X","volume":"13","author":"J M\u00f8ller","year":"2003","unstructured":"M\u00f8ller J (2003) Effects of growth hormone on fluid homeostasis. clinical and experimental aspects. Growth Hormon IGF Res 13:55\u201374","journal-title":"Growth Hormon IGF Res"},{"key":"5097_CR57","doi-asserted-by":"crossref","first-page":"E1326","DOI":"10.1152\/ajpendo.2001.281.6.E1326","volume":"281","author":"TK Hansen","year":"2001","unstructured":"Hansen TK, M\u00f8ller J, Thomsen K, Frandsen E, Dall R, J\u00f8rgensen JO, Christiansen JS (2001) Effects of growth hormone on renal tubular handling of sodium in healthy humans. Am J Physiol Endocrinol Metab 281:E1326\u2013E1332","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"5097_CR58","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2005-0553","volume":"90","author":"G Johannsson","year":"2005","unstructured":"Johannsson G, Gibney J, Wolthers T, Leung KC, Ho KK (2005) Independent and combined effects of testosterone and growth hormone on extracellular water in hypopituitary men. J Clin Endocrinol Metab 90:3989\u20133994","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2265.2000.00931.x","volume":"52","author":"J M\u00f8ller","year":"2000","unstructured":"M\u00f8ller J, J\u00f8rgensen JO, Marqversen J, Frandsen E, Christiansen JS (2000) Insulin-like growth factor I administration induces fluid and sodium retention in healthy adults: possible involvement of renin and atrial natriuretic factor. Clin Endocrinol 52:181\u2013186","journal-title":"Clin Endocrinol"},{"key":"5097_CR60","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJM199105233242107","volume":"324","author":"JL Walker","year":"1991","unstructured":"Walker JL, Ginalska-Malinowska M, Romer TE, Pucilowska JB, Underwood LE (1991) Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (laron dwarfism). N Engl J Med 324:1483\u20131488","journal-title":"N Engl J Med"},{"key":"5097_CR61","doi-asserted-by":"crossref","first-page":"C612","DOI":"10.1152\/ajpcell.1989.257.4.C612","volume":"257","author":"BL Blazer-Yost","year":"1989","unstructured":"Blazer-Yost BL, Cox M, Furlanetto R (1989) Insulin and IGF I receptor-mediated na+ transport in toad urinary bladders. Am J Phys 257:C612\u2013C620","journal-title":"Am J Phys"},{"key":"5097_CR62","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1210\/jc.2011-0078","volume":"96","author":"P Kamenicky","year":"2011","unstructured":"Kamenicky P, Blanchard A, Frank M, Salenave S, Letierce A, Azizi M, Lomb\u00e8s M, Chanson P (2011) Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activity. J Clin Endocrinol Metab 96:2127\u20132135","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR63","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1210\/me.2009-0095","volume":"23","author":"S Viengchareun","year":"2009","unstructured":"Viengchareun S, Kamenicky P, Teixeira M, Butlen D, Meduri G, Blanchard-Gutton N, Kurschat C, Lanel A, Martinerie L, Sztal-Mazer S, Blot-Chabaud M, Ferrary E, Cherradi N, Lomb\u00e8s M (2009) Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line. Mol Endocrinol 23:1948\u20131962","journal-title":"Mol Endocrinol"},{"key":"5097_CR64","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/jcem-70-2-519","volume":"70","author":"R Marcus","year":"1990","unstructured":"Marcus R, Butterfield G, Holloway L, Gilliland L, Baylink DJ, Hintz RL, Sherman BM (1990) Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 70:519\u2013527","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2796.1997.94101000.x","volume":"241","author":"T Bianda","year":"1997","unstructured":"Bianda T, Hussain MA, Glatz Y, Bouillon R, Froesch ER, Schmid C (1997) Effects of short-term insulin-like growth factor-I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man. J Intern Med 241:143\u2013150","journal-title":"J Intern Med"},{"key":"5097_CR66","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endo.132.1.8419119","volume":"132","author":"T Nesbitt","year":"1993","unstructured":"Nesbitt T, Drezner MK (1993) Insulin-like growth factor-I regulation of renal 25-hydroxyvitamin D-1-hydroxylase activity. Endocrinology 132:133\u2013138","journal-title":"Endocrinology"},{"key":"5097_CR67","doi-asserted-by":"crossref","first-page":"25461","DOI":"10.1074\/jbc.270.43.25461","volume":"270","author":"C Menaa","year":"1995","unstructured":"Menaa C, Vrtovsnik F, Friedlander G, Corvol M, Garab\u00e9dian M (1995) Insulin-like growth factor I, a unique calcium-dependent stimulator of 1,25-dihydroxyvitamin D3 production. studies in cultured mouse kidney cells. J Biol Chem 270:25461\u201325467","journal-title":"J Biol Chem"},{"key":"5097_CR68","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1530\/eje.0.1390454","volume":"139","author":"S Wei","year":"1998","unstructured":"Wei S, Tanaka H, Seino Y (1998) Local action of exogenous growth hormone and insulin-like growth factor-I on dihydroxyvitamin D production in LLC-PK1 cells. Eur J Endocrinol 139:454\u2013460","journal-title":"Eur J Endocrinol"},{"key":"5097_CR69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-66653-2_1","volume":"1033","author":"S Christakos","year":"2017","unstructured":"Christakos S, Veldurthy V, Patel N, Wei R (2017) Intestinal regulation of calcium: vitamin D and bone physiology. Adv Exp Med Biol 1033:3\u201312","journal-title":"Adv Exp Med Biol"},{"key":"5097_CR70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jsbmb.2017.05.013","volume":"172","author":"M Ishizawa","year":"2017","unstructured":"Ishizawa M, Akagi D, Yamamoto J, Makishima M (2017) 1\u03b1,25-dihydroxyvitamin D(3) enhances TRPV6 transcription through p38 MAPK activation and GADD45 expression. J Steroid Biochem Mol Biol 172:55\u201361","journal-title":"J Steroid Biochem Mol Biol"},{"key":"5097_CR71","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1681\/ASN.V1271342","volume":"12","author":"JG Hoenderop","year":"2001","unstructured":"Hoenderop JG, M\u00fcller D, Van Der Kemp AW, Hartog A, Suzuki M, Ishibashi K, Imai M, Sweep F, Willems PH, Van Os CH, Bindels RJ (2001) Calcitriol controls the epithelial calcium channel in kidney. J Am Soc Nephrol 12:1342\u20131349","journal-title":"J Am Soc Nephrol"},{"key":"5097_CR72","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1210\/jc.2011-3188","volume":"97","author":"P Kamenick\u00fd","year":"2012","unstructured":"Kamenick\u00fd P, Blanchard A, Gauci C, Salenave S, Letierce A, Lomb\u00e8s M, Brailly-Tabard S, Azizi M, Pri\u00e9 D, Souberbielle JC, Chanson P (2012) Pathophysiology of renal calcium handling in acromegaly: what lies behind hypercalciuria? J Clin Endocrinol Metab 97:2124\u20132133","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00223-012-9619-0","volume":"92","author":"MR Haussler","year":"2013","unstructured":"Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh JC, Jurutka PW (2013) Molecular mechanisms of vitamin D action. Calcif Tissue Int 92:77\u201398","journal-title":"Calcif Tissue Int"},{"key":"5097_CR74","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1542\/peds.102.6.1407","volume":"102","author":"NS Glaser","year":"1998","unstructured":"Glaser NS, Shirali AC, Styne DM, Jones KL (1998) Acid-base homeostasis in children with growth hormone deficiency. Pediatrics 102:1407\u20131414","journal-title":"Pediatrics"},{"key":"5097_CR75","first-page":"R1036","volume":"260","author":"TC Welbourne","year":"1991","unstructured":"Welbourne TC, Cronin MJ (1991) Growth hormone accelerates tubular acid secretion. Am J Phys 260:R1036\u2013R1042","journal-title":"Am J Phys"},{"key":"5097_CR76","first-page":"F878","volume":"262","author":"MC Chobanian","year":"1992","unstructured":"Chobanian MC, Julin CM, Molteni KH, Brazy PC (1992) Growth hormone regulates ammoniagenesis in canine renal proximal tubule segments. Am J Phys 262:F878\u2013F884","journal-title":"Am J Phys"},{"key":"5097_CR77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/CS19990317","volume":"99","author":"S Jehle","year":"2000","unstructured":"Jehle S, Hulter HN, Krapf R (2000) On the mechanism of growth hormone-induced stimulation of renal acidification in humans: effect of dietary NaCl. Clin Sci (Lond) 99:47\u201356","journal-title":"Clin Sci (Lond)"},{"key":"5097_CR78","doi-asserted-by":"publisher","unstructured":"Legouis D, Faivre A, Cipp\u00e0 PE, de Seigneux S (2020) Renal gluconeogenesis: an underestimated role of the kidney in systemic glucose metabolism. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfaa302","DOI":"10.1093\/ndt\/gfaa302"},{"key":"5097_CR79","first-page":"E751","volume":"257","author":"SA Rogers","year":"1989","unstructured":"Rogers SA, Karl IE, Hammerman MR (1989) Growth hormone directly stimulates gluconeogenesis in canine renal proximal tubule. Am J Phys 257:E751\u2013E756","journal-title":"Am J Phys"},{"key":"5097_CR80","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2215\/CJN.02840320","volume":"16","author":"JA Neyra","year":"2020","unstructured":"Neyra JA, Hu MC, Moe OW (2020) Klotho in clinical nephrology: diagnostic and therapeutic implications. Clin J Am Soc Nephrol 16:162\u2013176","journal-title":"Clin J Am Soc Nephrol"},{"key":"5097_CR81","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fendo.2018.00267","volume":"9","author":"RG Erben","year":"2018","unstructured":"Erben RG (2018) Physiological actions of fibroblast growth factor-23. Front Endocrinol (Lausanne) 9:267","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5097_CR82","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000509369","volume":"6","author":"X Bi","year":"2020","unstructured":"Bi X, Yang K, Zhang B, Zhao J (2020) The protective role of klotho in CKD-associated cardiovascular disease. Kidney Dis (Basel) 6:395\u2013406","journal-title":"Kidney Dis (Basel)"},{"key":"5097_CR83","doi-asserted-by":"crossref","first-page":"327-z","DOI":"10.1186\/s12882-018-1114-z","volume":"19","author":"AY Adema","year":"2018","unstructured":"Adema AY, de Roij van Zuijdewijn CLM, Hoenderop JG, de Borst MH, Ter Wee PM, Heijboer AC, Vervloet MG, NIGRAM consortium (2018) Influence of exogenous growth hormone administration on circulating concentrations of \u03b1-klotho in healthy and chronic kidney disease subjects: a prospective, single-center open case-control pilot study. BMC Nephrol 19:327-z","journal-title":"BMC Nephrol"},{"key":"5097_CR84","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/cen.12756","volume":"83","author":"R Locher","year":"2015","unstructured":"Locher R, Egger A, Zwimpfer C, Sze L, Schmid C, Christ E (2015) Effect of growth hormone replacement therapy on soluble klotho in patients with growth hormone deficiency. Clin Endocrinol 83:593\u2013595","journal-title":"Clin Endocrinol"},{"key":"5097_CR85","doi-asserted-by":"publisher","unstructured":"Ewert A, Leifheit-Nestler M, Hohenfellner K, B\u00fcscher A, Kemper MJ, Oh J, Billing H, Thumfart J, Stangl G, Baur AC, F\u00f6ller M, Feger M, Weber LT, Acham-Roschitz B, Arbeiter K, T\u00f6nshoff B, Zivicnjak M, Haffner D (2020) Bone and mineral metabolism in children with nephropathic cystinosis compared with other CKD entities. J Clin Endocrinol Metab 105:dgaa267. https:\/\/doi.org\/10.1210\/clinem\/dgaa267","DOI":"10.1210\/clinem\/dgaa267"},{"key":"5097_CR86","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00467-016-3505-3","volume":"32","author":"D Haffner","year":"2017","unstructured":"Haffner D, Leifheit-Nestler M (2017) Extrarenal effects of FGF23. Pediatr Nephrol 32:753\u2013765","journal-title":"Pediatr Nephrol"},{"key":"5097_CR87","doi-asserted-by":"crossref","first-page":"E326","DOI":"10.1152\/ajpendo.00090.2014","volume":"307","author":"S Shahmoon","year":"2014","unstructured":"Shahmoon S, Rubinfeld H, Wolf I, Cohen ZR, Hadani M, Shimon I, Rubinek T (2014) The aging suppressor klotho: a potential regulator of growth hormone secretion. Am J Physiol Endocrinol Metab 307:E326\u2013E334","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"5097_CR88","volume":"9","author":"I Wolf","year":"2014","unstructured":"Wolf I, Shahmoon S, Ben Ami M, Levy-Shraga Y, Mazor-Aronovitch K, Pinhas-Hamiel O, Yeshayahu Y, Hemi R, Kanety H, Rubinek T, Modan-Moses D (2014) Association between decreased klotho blood levels and organic growth hormone deficiency in children with growth impairment. PLoS One 9:e107174","journal-title":"PLoS One"},{"key":"5097_CR89","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ecl.2020.05.007","volume":"49","author":"L Kasuki","year":"2020","unstructured":"Kasuki L, Antunes X, Lamback EB, Gadelha MR (2020) Acromegaly: update on management and long-term morbidities. Endocrinol Metab Clin N Am 49:475\u2013486","journal-title":"Endocrinol Metab Clin N Am"},{"key":"5097_CR90","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1530\/EJE-10-0007","volume":"162","author":"RS Auriemma","year":"2010","unstructured":"Auriemma RS, Galdiero M, De Martino MC, De Leo M, Grasso LF, Vitale P, Cozzolino A, Lombardi G, Colao A, Pivonello R (2010) The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. Eur J Endocrinol 162:1035\u20131042","journal-title":"Eur J Endocrinol"},{"key":"5097_CR91","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/EJE-17-0872","volume":"178","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Li Q, He W, Qiu H, Ye H, Wang Y, Shen M, He M, Yu Y, Shou X, Huang C, Yu H, Huang G, Tang W, Geng D, Fu C, Liu C, Ma Z, Ye Z, Zhang Q, Zhang Y, Shen Y, Yang Y, Wang M, Liu X, Lu Y, Hu R, Mao Y, Zhou L, Li Y, Li S, Tritos NA, Zhao Y (2018) The comprehensive impact on human body induced by resolution of growth hormone excess. Eur J Endocrinol 178:365\u2013375","journal-title":"Eur J Endocrinol"},{"key":"5097_CR92","first-page":"75","volume":"56","author":"M Takai","year":"2001","unstructured":"Takai M, Izumino K, Oda Y, Terada Y, Inoue H, Takata M (2001) Focal segmental glomerulosclerosis associated with acromegaly. Clin Nephrol 56:75\u201377","journal-title":"Clin Nephrol"},{"key":"5097_CR93","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0272-6386(99)70156-3","volume":"33","author":"H Yoshida","year":"1999","unstructured":"Yoshida H, Akikusa B, Saeki N, Hasegawa S, Iesato K, Yamamoto S, Murotani N, Wakashin M, Shimada T (1999) Effect of pituitary microsurgery on acromegaly complicated nephrotic syndrome with focal segmental glomerulosclerosis: Report of a rare clinical case. Am J Kidney Dis 33:1158\u20131163","journal-title":"Am J Kidney Dis"},{"key":"5097_CR94","doi-asserted-by":"crossref","first-page":"563020","DOI":"10.3389\/fmed.2020.563020","volume":"7","author":"R Wang","year":"2021","unstructured":"Wang R, Wu Y, An D, Ma P, Guo Y, Tang L (2021) Case report: glucocorticoids combined with immunosuppressant in the treatment of acromegaly complicated with focal segmental glomerulosclerosis. Front Med (Lausanne) 7:563020","journal-title":"Front Med (Lausanne)"},{"key":"5097_CR95","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI114737","volume":"86","author":"J Timsit","year":"1990","unstructured":"Timsit J, Riou B, Bertherat J, Wisnewsky C, Kato NS, Weisberg AS, Lubetzki J, Lecarpentier Y, Winegrad S, Mercadier JJ (1990) Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest 86:507\u2013515","journal-title":"J Clin Invest"},{"key":"5097_CR96","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-16-0242","volume":"175","author":"S Fujio","year":"2016","unstructured":"Fujio S, Takano K, Arimura H, Habu M, Bohara M, Hirano H, Hanaya R, Nishio Y, Koriyama C, Kinoshita Y, Arita K (2016) Treatable glomerular hyperfiltration in patients with active acromegaly. Eur J Endocrinol 175:325\u2013333","journal-title":"Eur J Endocrinol"},{"key":"5097_CR97","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1530\/acta.0.1290151","volume":"129","author":"K Hoogenberg","year":"1993","unstructured":"Hoogenberg K, Sluiter WJ, Dullaart RP (1993) Effect of growth hormone and insulin-like growth factor I on urinary albumin excretion: studies in acromegaly and growth hormone deficiency. Acta Endocrinol 129:151\u2013157","journal-title":"Acta Endocrinol"},{"key":"5097_CR98","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ando.2011.08.001","volume":"72","author":"S Grunenwald","year":"2011","unstructured":"Grunenwald S, Tack I, Chauveau D, Bennet A, Caron P (2011) Impact of growth hormone hypersecretion on the adult human kidney. Ann Endocrinol (Paris) 72:485\u2013495","journal-title":"Ann Endocrinol (Paris)"},{"key":"5097_CR99","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1210\/jc.2007-1197","volume":"93","author":"R Baldelli","year":"2008","unstructured":"Baldelli R, De Marinis L, Bianchi A, Pivonello R, Gasco V, Auriemma R, Pasimeni G, Cimino V, Appetecchia M, Maccario M, Lombardi G, Pontecorvi A, Colao A, Grottoli S (2008) Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor. J Clin Endocrinol Metab 93:710\u2013714","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR100","doi-asserted-by":"publisher","unstructured":"Kamenick\u00fd P, Maione L, Chanson P (2020) Cardiovascular complications of acromegaly. Ann Endocrinol (Paris) 18:S0003-4266(20)30045-7. https:\/\/doi.org\/10.1016\/j.ando.2020.03.010","DOI":"10.1016\/j.ando.2020.03.010"},{"key":"5097_CR101","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1172\/JCI102977","volume":"33","author":"D Ikkos","year":"1954","unstructured":"Ikkos D, Luft R, Sjogren B (1954) Body water and sodium in patients with acromegaly. J Clin Invest 33:989\u2013994","journal-title":"J Clin Invest"},{"key":"5097_CR102","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJM198703053161003","volume":"316","author":"G Deray","year":"1987","unstructured":"Deray G, Rieu M, Devynck MA, Pernollet MG, Chanson P, Luton JP, Meyer P (1987) Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly. N Engl J Med 316:575\u2013580","journal-title":"N Engl J Med"},{"key":"5097_CR103","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM197210192871604","volume":"287","author":"G Strauch","year":"1972","unstructured":"Strauch G, Vallotton MB, Touitou Y, Bricaire H (1972) The renin\u2013angiotensin\u2013aldosterone system in normotensive and hypertensive patients with acromegaly. N Engl J Med 287:795\u2013799","journal-title":"N Engl J Med"},{"key":"5097_CR104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000441-196901000-00001","volume":"257","author":"EZ Hirsch","year":"1969","unstructured":"Hirsch EZ, Sloman JG, Martin FI (1969) Cardiac function in acromegaly. Am J Med Sci 257:1\u20138","journal-title":"Am J Med Sci"},{"key":"5097_CR105","doi-asserted-by":"crossref","first-page":"577173","DOI":"10.3389\/fendo.2020.577173","volume":"11","author":"G Vila","year":"2020","unstructured":"Vila G, Luger A, van der Lely AJ, Neggers SJCMM, Webb SM, Biller BMK, Valluri S, Hey-Hadavi J (2020) Hypertension in acromegaly in relationship to biochemical control and mortality: global ACROSTUDY outcomes. Front Endocrinol (Lausanne) 11:577173","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5097_CR106","doi-asserted-by":"crossref","first-page":"410","DOI":"10.21037\/qims-20-159","volume":"11","author":"A Nemes","year":"2021","unstructured":"Nemes A, Korm\u00e1nyos \u00c1, Domsik P, Kalapos A, Gyenes N, Lengyel C, Valkusz Z (2021) Diabetes mellitus deteriorates left ventricular deformation in acromegaly-analysis from the three-dimensional speckle-tracking echocardiographic MAGYAR-path study. Quant Imaging Med Surg 11:410\u2013414","journal-title":"Quant Imaging Med Surg"},{"key":"5097_CR107","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jocn.2019.11.012","volume":"71","author":"T Xie","year":"2020","unstructured":"Xie T, Tian P, Wu S, Zhang X, Liu T, Gu Y, Sun C, Hu F (2020) Serum phosphate: does it more closely reflect the true state of acromegaly? J Clin Neurosci 71:26\u201331","journal-title":"J Clin Neurosci"},{"key":"5097_CR108","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4158\/EP13228.CR","volume":"20","author":"P Manroa","year":"2014","unstructured":"Manroa P, Kannan S, Hatipoglu B, Licata A (2014) Hypercalcemia and acromegaly--clarifying the connections. A case report and review of the literature. Endocr Pract 20:86","journal-title":"Endocr Pract"},{"key":"5097_CR109","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.physiol.69.031905.161003","volume":"70","author":"Y Suzuki","year":"2008","unstructured":"Suzuki Y, Landowski CP, Hediger MA (2008) Mechanisms and regulation of epithelial Ca2+ absorption in health and disease. Annu Rev Physiol 70:257\u2013271","journal-title":"Annu Rev Physiol"},{"key":"5097_CR110","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1210\/jc.2013-1460","volume":"98","author":"G Mazziotti","year":"2013","unstructured":"Mazziotti G, Bianchi A, Porcelli T, Mormando M, Maffezzoni F, Cristiano A, Giampietro A, De Marinis L, Giustina A (2013) Vertebral fractures in patients with acromegaly: a 3-year prospective study. J Clin Endocrinol Metab 98:3402\u20133410","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR111","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2796.2012.02542.x","volume":"272","author":"L Sze","year":"2012","unstructured":"Sze L, Bernays RL, Zwimpfer C, Wiesli P, Br\u00e4ndle M, Schmid C (2012) Excessively high soluble klotho in patients with acromegaly. J Intern Med 272:93\u201397","journal-title":"J Intern Med"},{"key":"5097_CR112","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1530\/JOE-13-0285","volume":"219","author":"C Schmid","year":"2013","unstructured":"Schmid C, Neidert MC, Tschopp O, Sze L, Bernays RL (2013) Growth hormone and klotho. J Endocrinol 219:R37\u2013R57","journal-title":"J Endocrinol"},{"key":"5097_CR113","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.vh.2016.02.009","volume":"101","author":"T Rubinek","year":"2016","unstructured":"Rubinek T, Modan-Moses D (2016) Klotho and the growth hormone\/insulin-like growth factor 1 axis: novel insights into complex interactions. Vitam Horm 101:85\u2013118","journal-title":"Vitam Horm"},{"key":"5097_CR114","first-page":"601","volume":"65","author":"CM Pesce","year":"1991","unstructured":"Pesce CM, Striker LJ, Peten E, Elliot SJ, Striker GE (1991) Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Investig 65:601\u2013605","journal-title":"Lab Investig"},{"key":"5097_CR115","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1111\/j.1523-1755.2005.00656.x","volume":"68","author":"MO Machado","year":"2005","unstructured":"Machado MO, Hirata RD, Sellitti DF, Iotti R, Iotti A, Cusumano AM, Riordan GP, Coschigano KT, Kopchick JJ, Zuhl I, Nguyen N, Hirata MH, Doi SQ (2005) Growth hormone promotes glomerular lipid accumulation in bGH mice. Kidney Int 68:2019\u20132028","journal-title":"Kidney Int"},{"key":"5097_CR116","first-page":"91","volume":"20","author":"LJ Striker","year":"1991","unstructured":"Striker LJ, Doi T, Striker GE (1991) Transgenic mice in renal research. Adv Nephrol Necker Hosp 20:91\u2013108","journal-title":"Adv Nephrol Necker Hosp"},{"key":"5097_CR117","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1084\/jem.173.5.1287","volume":"173","author":"T Doi","year":"1991","unstructured":"Doi T, Striker LJ, Kimata K, Peten EP, Yamada Y, Striker GE (1991) Glomerulosclerosis in mice transgenic for growth hormone. increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med 173:1287\u20131290","journal-title":"J Exp Med"},{"key":"5097_CR118","first-page":"62","volume":"68","author":"CW Yang","year":"1993","unstructured":"Yang CW, Striker LJ, Pesce C, Chen WY, Peten EP, Elliot S, Doi T, Kopchick JJ, Striker GE (1993) Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone. studies in transgenic mice. Lab Investig 68:62\u201370","journal-title":"Lab Investig"},{"key":"5097_CR119","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev.nutr.19.1.437","volume":"19","author":"JJ Kopchick","year":"1999","unstructured":"Kopchick JJ, Bellush LL, Coschigano KT (1999) Transgenic models of growth hormone action. Annu Rev Nutr 19:437\u2013461","journal-title":"Annu Rev Nutr"},{"key":"5097_CR120","first-page":"398","volume":"131","author":"T Doi","year":"1988","unstructured":"Doi T, Striker LJ, Quaife C, Conti FG, Palmiter R, Behringer R, Brinster R, Striker GE (1988) Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol 131:398\u2013403","journal-title":"Am J Pathol"},{"key":"5097_CR121","first-page":"541","volume":"137","author":"T Doi","year":"1990","unstructured":"Doi T, Striker LJ, Gibson CC, Agodoa LY, Brinster RL, Striker GE (1990) Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. relationship between increased glomerular size and mesangial sclerosis. Am J Pathol 137:541\u2013552","journal-title":"Am J Pathol"},{"key":"5097_CR122","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mce.2014.07.002","volume":"394","author":"A Blutke","year":"2014","unstructured":"Blutke A, Schneider MR, Renner-M\u00fcller I, Herbach N, Wanke R, Wolf E (2014) Genetic dissection of IGF1-dependent and -independent effects of permanent GH excess on postnatal growth and organ pathology of mice. Mol Cell Endocrinol 394:88\u201398","journal-title":"Mol Cell Endocrinol"},{"key":"5097_CR123","doi-asserted-by":"publisher","first-page":"e12709","DOI":"10.14814\/phy2.12709","volume":"4","author":"A Blutke","year":"2016","unstructured":"Blutke A, Schneider MR, Wolf E, Wanke R (2016) Growth hormone (GH)-transgenic insulin-like growth factor 1 (IGF1)-deficient mice allow dissociation of excess GH and IGF1 effects on glomerular and tubular growth. Phys Rep 4:e12709. https:\/\/doi.org\/10.14814\/phy2.12709","journal-title":"Phys Rep"},{"key":"5097_CR124","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF01453692","volume":"5","author":"E Ritz","year":"1991","unstructured":"Ritz E, T\u00f6nshoff B, Worgall S, Kovacs G, Mehls O (1991) Influence of growth hormone and insulin-like growth factor-I on kidney function and kidney growth. Pediatr Nephrol 5:509\u2013512","journal-title":"Pediatr Nephrol"},{"key":"5097_CR125","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/en.2006-0385","volume":"148","author":"C Moerth","year":"2007","unstructured":"Moerth C, Schneider MR, Renner-Mueller I, Blutke A, Elmlinger MW, Erben RG, Camacho-H\u00fcbner C, Hoeflich A, Wolf E (2007) Postnatally elevated levels of insulin-like growth factor (IGF)-II fail to rescue the dwarfism of IGF-I-deficient mice except kidney weight. Endocrinology 148:441\u2013451","journal-title":"Endocrinology"},{"key":"5097_CR126","first-page":"59","volume":"75","author":"JP Liu","year":"1993","unstructured":"Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59\u201372","journal-title":"Cell"},{"key":"5097_CR127","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJM199610313351805","volume":"335","author":"KA Woods","year":"1996","unstructured":"Woods KA, Camacho-H\u00fcbner C, Savage MO, Clark AJ (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363\u20131367","journal-title":"N Engl J Med"},{"key":"5097_CR128","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM198910123211501","volume":"321","author":"S Amselem","year":"1989","unstructured":"Amselem S, Duquesnoy P, Attree O, Novelli G, Bousnina S, Postel-Vinay MC, Goossens M (1989) Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med 321:989\u2013995","journal-title":"N Engl J Med"},{"key":"5097_CR129","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1210\/jcem-62-4-712","volume":"62","author":"M Goossens","year":"1986","unstructured":"Goossens M, Brauner R, Czernichow P, Duquesnoy P, Rappaport R (1986) Isolated growth hormone (GH) deficiency type 1A associated with a double deletion in the human GH gene cluster. J Clin Endocrinol Metab 62:712\u2013716","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1530\/acta.0.0460080","volume":"46","author":"T Falkheden","year":"1964","unstructured":"Falkheden T, Sjoegren B (1964) Extracellular fluid volume and renal function in pituitary insufficiency and acromegaly. Acta Endocrinol 46:80\u201388","journal-title":"Acta Endocrinol"},{"key":"5097_CR131","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2265.2001.01413.x","volume":"55","author":"K Link","year":"2001","unstructured":"Link K, B\u00fclow B, Westman K, Salmonsson EC, Eskilsson J, Erfurth EM (2001) Low individualized growth hormone (GH) dose increased renal and cardiac growth in young adults with childhood onset GH deficiency. Clin Endocrinol 55:741\u2013748","journal-title":"Clin Endocrinol"},{"key":"5097_CR132","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1210\/jc.2006-1610","volume":"92","author":"SD Chernausek","year":"2007","unstructured":"Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE, GH Insensitivity Syndrome Collaborative Group (2007) Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab 92:902\u2013910","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR133","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/BF00869089","volume":"8","author":"B Klinger","year":"1994","unstructured":"Klinger B, Laron Z (1994) Renal function in laron syndrome patients treated by insulin-like growth factor-I. Pediatr Nephrol 8:684\u2013688","journal-title":"Pediatr Nephrol"},{"key":"5097_CR134","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2265.1994.tb03937.x","volume":"40","author":"K Caidahl","year":"1994","unstructured":"Caidahl K, Ed\u00e9n S, Bengtsson BA (1994) Cardiovascular and renal effects of growth hormone. Clin Endocrinol 40:393\u2013400","journal-title":"Clin Endocrinol"},{"key":"5097_CR135","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","volume":"1","author":"JO J\u00f8rgensen","year":"1989","unstructured":"J\u00f8rgensen JO, Pedersen SA, Thuesen L, J\u00f8rgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS (1989) Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1:1221\u20131225","journal-title":"Lancet"},{"key":"5097_CR136","first-page":"1123","volume":"81","author":"DM Hoffman","year":"1996","unstructured":"Hoffman DM, Crampton L, Sernia C, Nguyen TV, Ho KK (1996) Short-term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure. J Clin Endocrinol Metab 81:1123\u20131128","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR137","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","volume":"16","author":"H de Boer","year":"1995","unstructured":"de Boer H, Blok GJ, Van der Veen EA (1995) Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63\u201386","journal-title":"Endocr Rev"},{"key":"5097_CR138","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1210\/edrv-12-3-189","volume":"12","author":"JO J\u00f8rgensen","year":"1991","unstructured":"J\u00f8rgensen JO (1991) Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocr Rev 12:189\u2013207","journal-title":"Endocr Rev"},{"key":"5097_CR139","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11154-020-09604-2","volume":"22","author":"MCS Boguszewski","year":"2021","unstructured":"Boguszewski MCS (2021) Growth hormone deficiency and replacement in children. Rev Endocr Metab Disord 22:101\u2013108. https:\/\/doi.org\/10.1007\/s11154-020-09604-2","journal-title":"Rev Endocr Metab Disord"},{"key":"5097_CR140","first-page":"309","volume":"76","author":"BA Bengtsson","year":"1993","unstructured":"Bengtsson BA, Ed\u00e9n S, L\u00f6nn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, T\u00f6lli J, Sj\u00f6str\u00f6m L, Isaksson OG (1993) Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309\u2013317","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR141","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2265.1995.tb01872.x","volume":"42","author":"SA Beshyah","year":"1995","unstructured":"Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG (1995) The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clin Endocrinol 42:249\u2013254","journal-title":"Clin Endocrinol"},{"key":"5097_CR142","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2265.1994.tb03936.x","volume":"40","author":"SA Beshyah","year":"1994","unstructured":"Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG (1994) The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol 40:383\u2013391","journal-title":"Clin Endocrinol"},{"key":"5097_CR143","first-page":"3352","volume":"81","author":"TB Hansen","year":"1996","unstructured":"Hansen TB, Brixen K, Vahl N, J\u00f8rgensen JO, Christiansen JS, Mosekilde L, Hagen C (1996) Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. J Clin Endocrinol Metab 81:3352\u20133359","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR144","first-page":"273","volume":"77","author":"MA Vaccarello","year":"1993","unstructured":"Vaccarello MA, Diamond FB Jr, Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Gargosky S, Cohen P, Wilson K, Rosenfeld RG (1993) Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency\/laron syndrome. J Clin Endocrinol Metab 77:273\u2013280","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR145","first-page":"81","volume":"83","author":"T Bianda","year":"1998","unstructured":"Bianda T, Glatz Y, Bouillon R, Froesch ER, Schmid C (1998) Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults. J Clin Endocrinol Metab 83:81\u201387","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR146","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1530\/eje.0.1360045","volume":"136","author":"S Wei","year":"1997","unstructured":"Wei S, Tanaka H, Kubo T, Ono T, Kanzaki S, Seino Y (1997) Growth hormone increases serum 1,25-dihydroxyvitamin D levels and decreases 24,25-dihydroxyvitamin D levels in children with growth hormone deficiency. Eur J Endocrinol 136:45\u201351","journal-title":"Eur J Endocrinol"},{"key":"5097_CR147","first-page":"1686","volume":"85","author":"N Mauras","year":"2000","unstructured":"Mauras N, O'Brien KO, Welch S, Rini A, Helgeson K, Vieira NE, Yergey AL (2000) Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J Clin Endocrinol Metab 85:1686\u20131694","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR148","first-page":"2423","volume":"82","author":"AM Boot","year":"1997","unstructured":"Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer-Schrama SM (1997) Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab 82:2423\u20132428","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR149","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3476(05)83484-5","volume":"122","author":"G Saggese","year":"1993","unstructured":"Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G (1993) Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 122:37\u201345","journal-title":"J Pediatr"},{"key":"5097_CR150","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3389\/fphys.2020.00725","volume":"11","author":"Z McArdle","year":"2020","unstructured":"McArdle Z, Schreuder MF, Moritz KM, Denton KM, Singh RR (2020) Physiology and pathophysiology of compensatory adaptations of a solitary functioning kidney. Front Physiol 11:725","journal-title":"Front Physiol"},{"key":"5097_CR151","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3109\/0886022X.2013.875834","volume":"36","author":"A Ece","year":"2014","unstructured":"Ece A, \u00c7etinkaya S, Ek\u015fio\u011flu S, \u015eenel S, \u00d6zkasap S, Gini\u015f T, Sen V, \u015eahin C (2014) Kidney growth and renal functions under the growth hormone replacement therapy in children. Ren Fail 36:508\u2013513","journal-title":"Ren Fail"},{"key":"5097_CR152","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1210\/endo.130.5.1315253","volume":"130","author":"SE Mulroney","year":"1992","unstructured":"Mulroney SE, Lumpkin MD, Roberts CT Jr, LeRoith D, Haramati A (1992) Effect of a growth hormone-releasing factor antagonist on compensatory renal growth, insulin-like growth factor-I (IGF-I), and IGF-I receptor gene expression after unilateral nephrectomy in immature rats. Endocrinology 130:2697\u20132702","journal-title":"Endocrinology"},{"key":"5097_CR153","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1210\/endo.130.1.1309331","volume":"130","author":"SE Mulroney","year":"1992","unstructured":"Mulroney SE, Haramati A, Werner H, Bondy C, Roberts CT Jr, LeRoith D (1992) Altered expression of insulin-like growth factor-I (IGF-I) and IGF receptor genes after unilateral nephrectomy in immature rats. Endocrinology 130:249\u2013256","journal-title":"Endocrinology"},{"key":"5097_CR154","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41581-019-0161-4","volume":"15","author":"J Drube","year":"2019","unstructured":"Drube J, Wan M, Bonthuis M, W\u00fchl E, Bacchetta J, Santos F, Grenda R, Edefonti A, Harambat J, Shroff R, T\u00f6nshoff B, Haffner D, European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups (2019) Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol 15:577\u2013589","journal-title":"Nat Rev Nephrol"},{"key":"5097_CR155","first-page":"22","volume":"81","author":"F Schaefer","year":"1996","unstructured":"Schaefer F, Baumann G, Haffner D, Faunt LM, Johnson ML, Mercado M, Ritz E, Mehls O, Veldhuis JD (1996) Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma. J Clin Endocrinol Metab 81:22\u201331","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR156","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00467-004-1713-8","volume":"20","author":"R Rabkin","year":"2005","unstructured":"Rabkin R, Sun DF, Chen Y, Tan J, Schaefer F (2005) Growth hormone resistance in uremia, a role for impaired JAK\/STAT signaling. Pediatr Nephrol 20:313\u2013318","journal-title":"Pediatr Nephrol"},{"key":"5097_CR157","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1172\/JCI11895","volume":"108","author":"F Schaefer","year":"2001","unstructured":"Schaefer F, Chen Y, Tsao T, Nouri P, Rabkin R (2001) Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 108:467\u2013475","journal-title":"J Clin Invest"},{"key":"5097_CR158","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF01453698","volume":"5","author":"MC Postel-Vinay","year":"1991","unstructured":"Postel-Vinay MC, Tar A, Crosnier H, Broyer M, Rappaport R, Tonshoff B, Mehls O (1991) Plasma growth hormone-binding activity is low in uraemic children. Pediatr Nephrol 5:545\u2013547","journal-title":"Pediatr Nephrol"},{"key":"5097_CR159","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/j.ajkd.2014.05.024","volume":"65","author":"LA Bach","year":"2015","unstructured":"Bach LA, Hale LJ (2015) Insulin-like growth factors and kidney disease. Am J Kidney Dis 65:327\u2013336","journal-title":"Am J Kidney Dis"},{"issue":"351-74","key":"5097_CR160","first-page":"vii","volume":"41","author":"D Kiepe","year":"2012","unstructured":"Kiepe D, Tonshoff B (2012) Insulin-like growth factors in normal and diseased kidney. Endocrinol Metab Clin N Am 41(351-74):vii","journal-title":"Endocrinol Metab Clin N Am"},{"key":"5097_CR161","first-page":"1654","volume":"83","author":"DR Powell","year":"1998","unstructured":"Powell DR, Durham SK, Liu F, Baker BK, Lee PD, Watkins SL, Campbell PG, Brewer ED, Hintz RL, Hogg RJ (1998) The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the southwest pediatric nephrology study group. J Clin Endocrinol Metab 83:1654\u20131661","journal-title":"J Clin Endocrinol Metab"},{"key":"5097_CR162","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1172\/JCI118499","volume":"97","author":"H Ding","year":"1996","unstructured":"Ding H, Gao XL, Hirschberg R, Vadgama JV, Kopple JD (1996) Impaired actions of insulin-like growth factor 1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure. evidence for a postreceptor defect. J Clin Invest 97:1064\u20131075","journal-title":"J Clin Invest"},{"key":"5097_CR163","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00467-015-3179-2","volume":"31","author":"L Rees","year":"2016","unstructured":"Rees L (2016) Growth hormone therapy in children with CKD after more than two decades of practice. Pediatr Nephrol 31:1421\u20131435","journal-title":"Pediatr Nephrol"},{"key":"5097_CR164","first-page":"F747","volume":"259","author":"SB Miller","year":"1990","unstructured":"Miller SB, Hansen VA, Hammerman MR (1990) Effects of growth hormone and IGF-I on renal function in rats with normal and reduced renal mass. Am J Phys 259:F747\u2013F751","journal-title":"Am J Phys"},{"key":"5097_CR165","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1203\/00006450-198909000-00010","volume":"26","author":"M Nakano","year":"1989","unstructured":"Nakano M, Kainer G, Foreman JW, Ko DJ, Chan JC (1989) The effects of exogenous rat growth hormone therapy on growth of uremic rats fed an 8% protein diet. Pediatr Res 26:204\u2013207","journal-title":"Pediatr Res"},{"key":"5097_CR166","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1203\/00006450-199204000-00020","volume":"31","author":"DB Allen","year":"1992","unstructured":"Allen DB, Fogo A, El-Hayek R, Langhough R, Friedman AL (1992) Effects of prolonged growth hormone administration in rats with chronic renal insufficiency. Pediatr Res 31:406\u2013410","journal-title":"Pediatr Res"},{"key":"5097_CR167","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s004670050277","volume":"11","author":"H Kawaguchi","year":"1997","unstructured":"Kawaguchi H, Hattori M, Ito K (1997) Somatic and renal effects of growth hormone in rats with chronic renal failure. Pediatr Nephrol 11:280\u2013284","journal-title":"Pediatr Nephrol"},{"key":"5097_CR168","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/BF01453681","volume":"5","author":"B T\u00f6nshoff","year":"1991","unstructured":"T\u00f6nshoff B, Heinrich U, Mehls O (1991) How safe is the treatment of uraemic children with recombinant human growth hormone? Pediatr Nephrol 5:454\u2013460","journal-title":"Pediatr Nephrol"},{"key":"5097_CR169","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/BF00866727","volume":"9","author":"H Maxwell","year":"1995","unstructured":"Maxwell H, Nair DR, Dalton RN, Rigden SP, Rees L (1995) Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure. Pediatr Nephrol 9:458\u2013463","journal-title":"Pediatr Nephrol"},{"key":"5097_CR170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3476(96)70386-4","volume":"128","author":"H Maxwell","year":"1996","unstructured":"Maxwell H, Dalton RN, Nair DR, Turner C, Saunders AJ, Rigden SP, Rees L (1996) Effects of recombinant human growth hormone on renal function in children with renal transplants. J Pediatr 128:177\u2013183","journal-title":"J Pediatr"},{"key":"5097_CR171","volume":"2","author":"EM Hodson","year":"2012","unstructured":"Hodson EM, Willis NS, Craig JC (2012) Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev 2:CD003264 https:\/\/doi.org\/CD003264","journal-title":"Cochrane Database Syst Rev"},{"key":"5097_CR172","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1203\/00006450-199804000-00008","volume":"43","author":"E Wuhl","year":"1998","unstructured":"Wuhl E, Haffner D, Gretz N, Offner G, van't Hoff WG, Broyer M, Mehls O (1998) Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European study group on growth hormone treatment in short children with nephropathic cystinosis. Pediatr Res 43:484\u2013488","journal-title":"Pediatr Res"},{"key":"5097_CR173","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s00467-015-3157-8","volume":"30","author":"O Mehls","year":"2015","unstructured":"Mehls O, Lindberg A, Haffner D, Schaefer F, W\u00fchl E, German KIGS Board, ESCAPE Trial Group (2015) Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial. Pediatr Nephrol 30:2145\u20132151","journal-title":"Pediatr Nephrol"},{"key":"5097_CR174","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1159\/000508224","volume":"51","author":"D Landau","year":"2020","unstructured":"Landau D, Assadi MH, Abu Hilal R, Chen Y, Rabkin R, Segev Y (2020) SOCS2 silencing improves somatic growth without worsening kidney function in CKD. Am J Nephrol 51:520\u2013526","journal-title":"Am J Nephrol"},{"key":"5097_CR175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00467-012-2208-7","volume":"28","author":"Y Wu","year":"2013","unstructured":"Wu Y, Cheng W, Yang XD, Xiang B (2013) Growth hormone improves growth in pediatric renal transplant recipients\u2014a systemic review and meta-analysis of randomized controlled trials. Pediatr Nephrol 28:129\u2013133","journal-title":"Pediatr Nephrol"},{"key":"5097_CR176","first-page":"F917","volume":"264","author":"MH O'Shea","year":"1993","unstructured":"O'Shea MH, Miller SB, Hammerman MR (1993) Effects of IGF-I on renal function in patients with chronic renal failure. Am J Phys 264:F917\u2013F922","journal-title":"Am J Phys"},{"key":"5097_CR177","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ki.1994.260","volume":"46","author":"SB Miller","year":"1994","unstructured":"Miller SB, Moulton M, O'Shea M, Hammerman MR (1994) Effects of IGF-I on renal function in end-stage chronic renal failure. Kidney Int 46:201\u2013207","journal-title":"Kidney Int"},{"key":"5097_CR178","first-page":"R929","volume":"276","author":"A Vijayan","year":"1999","unstructured":"Vijayan A, Franklin SC, Behrend T, Hammerman MR, Miller SB (1999) Insulin-like growth factor I improves renal function in patients with end-stage chronic renal failure. Am J Phys 276:R929\u2013R934","journal-title":"Am J Phys"},{"key":"5097_CR179","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.ekir.2020.08.026","volume":"5","author":"Y Wen","year":"2020","unstructured":"Wen Y, Yang C, Menez SP, Rosenberg AZ, Parikh CR (2020) A systematic review of clinical characteristics and histologic descriptions of acute tubular injury. Kidney Int Rep 5:1993\u20132001","journal-title":"Kidney Int Rep"},{"key":"5097_CR180","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1073\/pnas.89.24.11876","volume":"89","author":"SB Miller","year":"1992","unstructured":"Miller SB, Martin DR, Kissane J, Hammerman MR (1992) Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci U S A 89:11876\u201311880","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5097_CR181","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1681\/ASN.V75710","volume":"7","author":"N Goes","year":"1996","unstructured":"Goes N, Urmson J, Vincent D, Ramassar V, Halloran PF (1996) Effect of recombinant human insulin-like growth factor-1 on the inflammatory response to acute renal injury. J Am Soc Nephrol 7:710\u2013720","journal-title":"J Am Soc Nephrol"},{"key":"5097_CR182","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1681\/ASN.V5101782","volume":"5","author":"M Friedlaender","year":"1995","unstructured":"Friedlaender M, Popovtzer MM, Weiss O, Nefesh I, Kopolovic J, Raz I (1995) Insulin-like growth factor-1 (IGF-1) enhances recovery from HgCl2-induced acute renal failure: the effects on renal IGF-1, IGF-1 receptor, and IGF-binding protein-1 mRNA. J Am Soc Nephrol 5:1782\u20131791","journal-title":"J Am Soc Nephrol"},{"key":"5097_CR183","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1172\/JCI116456","volume":"91","author":"H Ding","year":"1993","unstructured":"Ding H, Kopple JD, Cohen A, Hirschberg R (1993) Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 91:2281\u20132287","journal-title":"J Clin Invest"},{"key":"5097_CR184","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1096-6374(98)80105-6","volume":"8","author":"GL Matejka","year":"1998","unstructured":"Matejka GL, Bengtsson BA (1998) High dosage growth hormone treatment and post-ischemic acute renal failure in the rat. Growth Hormon IGF Res 8:151\u2013157","journal-title":"Growth Hormon IGF Res"},{"key":"5097_CR185","first-page":"F257","volume":"272","author":"SC Franklin","year":"1997","unstructured":"Franklin SC, Moulton M, Sicard GA, Hammerman MR, Miller SB (1997) Insulin-like growth factor I preserves renal function postoperatively. Am J Phys 272:F257\u2013F259","journal-title":"Am J Phys"},{"key":"5097_CR186","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/157339911794273900","volume":"7","author":"PA Kumar","year":"2011","unstructured":"Kumar PA, Brosius FC 3rd, Menon RK (2011) The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy. Curr Diabetes Rev 7:50\u201355","journal-title":"Curr Diabetes Rev"},{"key":"5097_CR187","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fmed.2017.00102","volume":"4","author":"D Mukhi","year":"2017","unstructured":"Mukhi D, Nishad R, Menon RK, Pasupulati AK (2017) Novel actions of growth hormone in podocytes: implications for diabetic nephropathy. Front Med (Lausanne) 4:102","journal-title":"Front Med (Lausanne)"},{"key":"5097_CR188","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/joe.0.1420453","volume":"142","author":"RK Menon","year":"1994","unstructured":"Menon RK, Stephan DA, Rao RH, Shen-Orr Z, Downs LS Jr, Roberts CT Jr, LeRoith D, Sperling MA (1994) Tissue-specific regulation of the growth hormone receptor gene in streptozocin-induced diabetes in the rat. J Endocrinol 142:453\u2013462","journal-title":"J Endocrinol"},{"key":"5097_CR189","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1172\/JCI200417763","volume":"113","author":"S Yakar","year":"2004","unstructured":"Yakar S, Setser J, Zhao H, Stannard B, Haluzik M, Glatt V, Bouxsein ML, Kopchick JJ, LeRoith D (2004) Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest 113:96\u2013105","journal-title":"J Clin Invest"},{"key":"5097_CR190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF03350189","volume":"11","author":"K Brismar","year":"1988","unstructured":"Brismar K, Gutniak M, Povoa G, Werner S, Hall K (1988) Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Investig 11:599\u2013602","journal-title":"J Endocrinol Investig"},{"key":"5097_CR191","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF03349888","volume":"19","author":"LR Salgado","year":"1996","unstructured":"Salgado LR, Semer M, Nery M, Knoepfelmacher M, Ler\u00e1rio AC, P\u00f3voa G, Jana S, Villares SM, Wajchenberg BL, Liberman B, Nicolau W (1996) Effect of glycemic control on growth hormone and IGFBP-1 secretion in patients with type I diabetes mellitus. J Endocrinol Investig 19:433\u2013440","journal-title":"J Endocrinol Investig"},{"key":"5097_CR192","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1203\/00006450-199606000-00011","volume":"39","author":"MT Mu\u00f1oz","year":"1996","unstructured":"Mu\u00f1oz MT, Barrios V, Pozo J, Argente J (1996) Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications. Pediatr Res 39:992\u2013998","journal-title":"Pediatr Res"},{"key":"5097_CR193","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1056\/NEJM199106063242304","volume":"324","author":"KR Tuttle","year":"1991","unstructured":"Tuttle KR, Bruton JL, Perusek MC, Lancaster JL, Kopp DT, DeFronzo RA (1991) Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 324:1626\u20131632","journal-title":"N Engl J Med"},{"key":"5097_CR194","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ki.1991.277","volume":"40","author":"Bank N","year":"1991","unstructured":"Bank N (1991) Mechanisms of diabetic hyperfiltration. Kidney Int 40:792\u2013807","journal-title":"Kidney Int"},{"key":"5097_CR195","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/jcb.25150","volume":"116","author":"PS Chitra","year":"2015","unstructured":"Chitra PS, Swathi T, Sahay R, Reddy GB, Menon RK, Kumar PA (2015) Growth hormone induces transforming growth factor-beta-induced protein in podocytes: implications for podocyte depletion and proteinuria. J Cell Biochem 116:1947\u20131956","journal-title":"J Cell Biochem"},{"key":"5097_CR196","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/labinvest.3780332","volume":"81","author":"P Aaltonen","year":"2001","unstructured":"Aaltonen P, Luimula P, Astr\u00f6m E, Palmen T, Gr\u00f6nholm T, Palojoki E, Jaakkola I, Ahola H, Tikkanen I, Holth\u00f6fer H (2001) Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Investig 81:1185\u20131190","journal-title":"Lab Investig"},{"key":"5097_CR197","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.ki.5002531","volume":"72","author":"D Verzola","year":"2007","unstructured":"Verzola D, Gandolfo MT, Ferrario F, Rastaldi MP, Villaggio B, Gianiorio F, Giannoni M, Rimoldi L, Lauria F, Miji M, Deferrari G, Garibotto G (2007) Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 72:1262\u20131272","journal-title":"Kidney Int"},{"key":"5097_CR198","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/diabetes.54.6.1626","volume":"54","author":"G Wolf","year":"2005","unstructured":"Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54:1626\u20131634","journal-title":"Diabetes"},{"key":"5097_CR199","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0026-0495(96)90094-3","volume":"45","author":"H Orskov","year":"1996","unstructured":"Orskov H (1996) Somatostatin, growth hormone, insulin-like growth factor-1, and diabetes: friends or foes? Metabolism 45:91\u201395","journal-title":"Metabolism"},{"key":"5097_CR200","first-page":"271","volume":"12","author":"A Verrotti","year":"1999","unstructured":"Verrotti A, Cieri F, Petitti MT, Morgese G, Chiarelli F (1999) Growth hormone and IGF-I in diabetic children with and without microalbuminuria. Diabetes Nutr Metab 12:271\u2013276","journal-title":"Diabetes Nutr Metab"},{"key":"5097_CR201","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2337\/diab.47.8.1341","volume":"47","author":"EA Cummings","year":"1998","unstructured":"Cummings EA, Sochett EB, Dekker MG, Lawson ML, Daneman D (1998) Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes 47:1341\u20131346","journal-title":"Diabetes"},{"key":"5097_CR202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1096-6374(98)80320-1","volume":"8","author":"D Landau","year":"1998","unstructured":"Landau D, Domene H, Flyvbjerg A, Gr\u00f8nbaek H, Roberts CT Jr, Argov S, LeRoith D (1998) Differential expression of renal growth hormone receptor and its binding protein in experimental diabetes mellitus. Growth Hormon IGF Res 8:39\u201345","journal-title":"Growth Hormon IGF Res"},{"key":"5097_CR203","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2337\/diabetes.48.2.377","volume":"48","author":"A Flyvbjerg","year":"1999","unstructured":"Flyvbjerg A, Bennett WF, Rasch R, Kopchick JJ, Scarlett JA (1999) Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. Diabetes 48:377\u2013382","journal-title":"Diabetes"},{"key":"5097_CR204","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1681\/ASN.V83436","volume":"8","author":"Y Segev","year":"1997","unstructured":"Segev Y, Landau D, Marbach M, Shehadeh N, Flyvbjerg A, Phillip M (1997) Renal hypertrophy in hyperglycemic nonobese diabetic mice is associated with persistent renal accumulation of insulin-like growth factor I. J Am Soc Nephrol 8:436\u2013444","journal-title":"J Am Soc Nephrol"},{"key":"5097_CR205","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0272-6386(98)70075-7","volume":"32","author":"IS Park","year":"1998","unstructured":"Park IS, Kiyomoto H, Alvarez F, Xu YC, Abboud HE, Abboud SL (1998) Preferential expression of insulin-like growth factor binding proteins-1, -3, and -5 during early diabetic renal hypertrophy in rats. Am J Kidney Dis 32:1000\u20131010","journal-title":"Am J Kidney Dis"},{"key":"5097_CR206","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.2008.403","volume":"74","author":"K Isshiki","year":"2008","unstructured":"Isshiki K, He Z, Maeno Y, Ma RC, Yasuda Y, Kuroki T, White GS, Patti ME, Weir GC, King GL (2008) Insulin regulates SOCS2 expression and the mitogenic effect of IGF-1 in mesangial cells. Kidney Int 74:1434\u20131443","journal-title":"Kidney Int"},{"key":"5097_CR207","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00285295","volume":"32","author":"A Flyvbjerg","year":"1989","unstructured":"Flyvbjerg A, Frystyk J, Thorlacius-Ussing O, Orskov H (1989) Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 32:261\u2013265","journal-title":"Diabetologia"},{"key":"5097_CR208","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1210\/endo.138.5.5123","volume":"138","author":"NY Chen","year":"1997","unstructured":"Chen NY, Chen WY, Kopchick JJ (1997) Liver and kidney growth hormone (GH) receptors are regulated differently in diabetic GH and GH antagonist transgenic mice. Endocrinology 138:1988\u20131994","journal-title":"Endocrinology"},{"key":"5097_CR209","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1210\/endo.136.2.7835300","volume":"136","author":"NY Chen","year":"1995","unstructured":"Chen NY, Chen WY, Bellush L, Yang CW, Striker LJ, Striker GE, Kopchick JJ (1995) Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice. Endocrinology 136:660\u2013667","journal-title":"Endocrinology"},{"key":"5097_CR210","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/endo.141.1.7284","volume":"141","author":"LL Bellush","year":"2000","unstructured":"Bellush LL, Doublier S, Holland AN, Striker LJ, Striker GE, Kopchick JJ (2000) Protection against diabetes-induced nephropathy in growth hormone receptor\/binding protein gene-disrupted mice. Endocrinology 141:163\u2013168","journal-title":"Endocrinology"},{"key":"5097_CR211","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1464-5491.1990.tb01394.x","volume":"7","author":"MM Pedersen","year":"1990","unstructured":"Pedersen MM, Christensen SE, Christiansen JS, Pedersen EB, Mogensen CE, Orskov H (1990) Acute effects of a somatostatin analogue on kidney function in type 1 diabetic patients. Diabet Med 7:304\u2013309","journal-title":"Diabet Med"},{"key":"5097_CR212","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jama.1991.03460070070045","volume":"265","author":"O Serri","year":"1991","unstructured":"Serri O, Beauregard H, Brazeau P, Abribat T, Lambert J, Harris A, Vachon L (1991) Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. JAMA 265:888\u2013892","journal-title":"JAMA"},{"key":"5097_CR213","doi-asserted-by":"crossref","first-page":"16109","DOI":"10.1074\/jbc.RA119.008966","volume":"294","author":"R Nishad","year":"2019","unstructured":"Nishad R, Mukhi D, Tahaseen SV, Mungamuri SK, Pasupulati AK (2019) Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy. J Biol Chem 294:16109\u201316122","journal-title":"J Biol Chem"},{"key":"5097_CR214","doi-asserted-by":"crossref","first-page":"117581","DOI":"10.1016\/j.lfs.2020.117581","volume":"253","author":"YF Mahran","year":"2020","unstructured":"Mahran YF (2020) New insights into the protection of growth hormone in cisplatin-induced nephrotoxicity: the impact of IGF-1 on the Keap1-Nrf2\/HO-1 signaling. Life Sci 253:117581","journal-title":"Life Sci"},{"key":"5097_CR215","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ki.1997.397","volume":"52","author":"D Haffner","year":"1997","unstructured":"Haffner D, Tonshoff B, Blum WF, Vickers M, Siebler T, Cronin MJ, Baxter RC, Mehls O (1997) Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic children. Kidney Int 52:802\u2013810","journal-title":"Kidney Int"},{"key":"5097_CR216","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00866783","volume":"10","author":"SM Feld","year":"1996","unstructured":"Feld SM, Hirschberg R (1996) Insulin-like growth factor-I and insulin-like growth factor-binding proteins in the nephrotic syndrome. Pediatr Nephrol 10:355\u2013358","journal-title":"Pediatr Nephrol"},{"key":"5097_CR217","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1210\/endo.136.4.7534704","volume":"136","author":"R Hirschberg","year":"1995","unstructured":"Hirschberg R, Kaysen GA (1995) Insulin-like growth factor I and its binding proteins in the experimental nephrotic syndrome. Endocrinology 136:1565\u20131571","journal-title":"Endocrinology"},{"key":"5097_CR218","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1172\/JCI118755","volume":"98","author":"R Hirschberg","year":"1996","unstructured":"Hirschberg R (1996) Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: evidence for a role for insulin-like growth factor I. J Clin Invest 98:116\u2013124","journal-title":"J Clin Invest"},{"key":"5097_CR219","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/ndt\/14.9.2072","volume":"14","author":"SN Wang","year":"1999","unstructured":"Wang SN, Hirschberg R (1999) Tubular epithelial cell activation and interstitial fibrosis. the role of glomerular ultrafiltration of growth factors in the nephrotic syndrome and diabetic nephropathy. Nephrol Dial Transplant 14:2072\u20132074","journal-title":"Nephrol Dial Transplant"},{"key":"5097_CR220","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/cen.14095","volume":"91","author":"WJ Goedegebuure","year":"2019","unstructured":"Goedegebuure WJ, Kerkhof GF, Hokken-Koelega ACS (2019) Glomerular filtration rate, blood pressure and microalbuminuria in adults born SGA: a 5-year longitudinal study after cessation of GH treatment. Clin Endocrinol 91:892\u2013898","journal-title":"Clin Endocrinol"},{"key":"5097_CR221","first-page":"500","volume":"59","author":"R Krysiak","year":"2007","unstructured":"Krysiak R, Gdula-Dymek A, Bednarska-Czerwi\u0144ska A, Okopie\u0144 B (2007) Growth hormone therapy in children and adults. Pharmacol Rep 59:500\u2013516","journal-title":"Pharmacol Rep"},{"key":"5097_CR222","volume":"14","author":"YJ Rhie","year":"2019","unstructured":"Rhie YJ, Yoo JH, Choi JH, Chae HW, Kim JH, Chung S, Hwang IT, Shin CH, Kim EY, Kim HS (2019) Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG growth study. PLoS One 14:e0216927","journal-title":"PLoS One"},{"key":"5097_CR223","first-page":"91","volume":"49","author":"DA Price","year":"1998","unstructured":"Price DA, Wilton P, J\u00f6nsson P, Albertsson-Wikland K, Chatelain P, Cutfield W, Ranke MB (1998) Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the pharmacia and upjohn international growth database (KIGS) from 1988 to 1996. Horm Res 49:91\u201397","journal-title":"Horm Res"},{"issue":"Suppl 3","key":"5097_CR224","first-page":"153","volume":"65","author":"WS Cutfield","year":"2006","unstructured":"Cutfield WS, Lindberg A, Rapaport R, Wajnrajch MP, Saenger P (2006) Safety of growth hormone treatment in children born small for gestational age: the US trial and KIGS analysis. Horm Res 65(Suppl 3):153\u2013159","journal-title":"Horm Res"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05097-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05097-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05097-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T09:48:16Z","timestamp":1625564896000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05097-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":224,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["5097"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05097-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"23 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}